2019 • 2018 • 2017 • 2016 • 2015 • 2014 • 2013 • 2012 • 2011 • 2010
2009 • 2008 • 2007 • 2006 • 2005 • 2004 • 2003 • 2002 • 2001 • 2000
— 2016 —
Afonso CL, Amarasinghe GK, Banyai K, Bao YM, Basler CF, Bavari S, Bejerman N, Blasdell KR, Briand FX, Briese T, Bukreyev A, Calisher CH, Chandran K, Cheng JS, Clawson AN, Collins PL, Dietzgen RG, Dolnik O, Domier LL, Durrwald R, Dye JM, Easton AJ, Ebihara H, Farkas SL, Freitas-Astua J, Formenty P, Fouchier RAM, Fu YP, Ghedin E, Goodin MM, Hewson R, Horie M, Hyndman TH, Jiang DH, Kitajima EW, Kobinger GP, Kondo H, Kurath G, Lamb RA, Lenardon S, Leroy EM, Li CX, Lin XD, Liu LJ, Longdon B, Marton S, Maisner A, Muhlberger E, Netesov SV, Nowotny N, Patterson JL, Payne SL, Paweska JT, Randall RE, Rima BK, Rota P, Rubbenstroth D, Schwemmle M, Shi M, Smither SJ, Stenglein MD, Stone DM, Takada A, Terregino C, Tesh RB, Tian JH, Tomonaga K, Tordo N, Towner JS, Vasilakis N, Verbeek M, Volchkov VE, Wahl-Jensen V, Walsh JA, Walker PJ, Wang D, Wang LF, Wetzel T, Whitfield AE, Xie JT, Yuen KY, Zhang YZ, Kuhn JH. Taxonomy of the order Mononegavirales: update 2016. Arch Virol. 2016;161(8):2351-60. doi: 10.1007/s00705-016-2880-1
Alves DA, Honko AN, Kortepeter MG, Sun M, Johnson JC, Lugo-Roman LA, Hensley LE. Necrotizing Scleritis, Conjunctivitis, and other pathologic findings in the left eye and brain of an Ebola virus-infected Rhesus Macaque (Macaca mulatta) with apparent recovery and a delayed time of death. J Infect Dis. 2016;213(1):57-60. doi: 10.1093/infdis/jiv357.
Andrews ES, Turell MJ. Effect of holding conditions on the detection of Chikungunya and Venezuelan Equine Encephalitis in mosquito pools. J Am Mosq Control Assoc. 2016;32(1):51-4.
Anthony SM, Rivas SC, Colpitts SL, Howard ME, Stonier SW, Schluns KS. Inflammatory signals regulate IL-15 in response to Lymphodepletion. J Immunol. 2016;196(11):4544-52. doi: 10.4049/jimmunol.1600219.
Bazzill JD, Cooper CL, Fan YC, Bavari S, Moon JJ. Lipid nanoparticles incorporated with Ebola glycoprotein for induction of humoral immunity against Ebola infection. J Immunol. 2016;196:2.
Bell TM, Bunton TE, Shaia CI, Raymond JW, Honnold SP, Donnelly GC, Shamblin JD, Wilkinson ER, Cashman KA. Pathogenesis of Bolivian hemorrhagic fever in guinea pigs. Vet Pathol. 2016;53(1):190-9. doi: 10.1177/0300985815588609.
Bengtsson KL, Song HF, Stertman L, Liu Y, Flyer DC, Massare MJ, Xu RH, Zhou B, Lu HX, Kwilas SA, Hahn TJ, Kpamegan E, Hooper J, Carrion R, Glenn G, Smith G. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice. Vaccine. 2016;34(16):1927-35. doi: 10.1016/j.vaccine.2016.02.033.
Booth L, Roberts JL, Ecroyd H, Tritsch SR, Bavari S, Reid S, Proniuk S, Zukiwski A, Jacob A, Sepulveda CS, Giovannoni F, Garcia CC, Damonte E, Gonzalez-Gallego J, Tunon MJ, Dent P. AR-12 inhibits multiple chaperones concomitant with stimulating autophagosome formation collectively preventing virus replication. J Cell Physiol. 2016;231(10):2286-302. doi: 10.1002/jcp.25431.
Bornholdt ZA, Turner HL, Murin CD, Li W, Sok D, Souders CA, Piper AE, Goff A, Shamblin JD, Wollen SE, Sprague TR, Fusco ML, Pommert KBJ, Cavacini LA, Smith HL, Klempner M, Reimann KA, Krauland E, Gerngross TU, Wittrup KD, Saphire EO, Burton DR, Glass PJ, Ward AB, Walker LM. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Science. 2016;351(6277):1078-83. doi: 10.1126/science.aad5788.
Bozue JA, Chaudhury S, Amemiya K, Chua J, Cote CK, Toothman RG, Dankmeyer JL, Klimko CP, Wilhelmsen CL, Raymond JW, Zavaljevski N, Reifman J, Wallqvist A. Phenotypic characterization of a novel virulence-factor deletion strain of Burkholderia mallei that provides partial protection against inhalational glanders in mice. Front Cell Infect Microbiol. 2016;6:15. doi: 10.3389/fcimb.2016.00021.
Brey RN, Mantis NJ, Pincus SH, Vitetta ES, Smith LA, Roy CJ. Recent advances in the development of vaccines against ricin. Hum Vaccin Immunother. 2016;12(5):1196-201. doi: 10.1080/21645515.2015.1124202.
Brovedani V, Sosa S, Poli M, Forino M, Varello K, Tubaro A, Pelin M. A revisited hemolytic assay for palytoxin detection: Limitations for its quantitation in mussels. Toxicon. 2016;119:225-33. doi: 10.1016/j.toxicon.2016.06.013.
Burk R, Bollinger L, Johnson JC, Wada J, Radoshitzky SR, Palacios G, Bavari S, Jahrling PB, Kuhn JH. Neglected filoviruses. FEMS Microbiol Rev. 2016;40(4):494-519. doi: 10.1093/femsre/fuw010.
Burnouf T, Conton B, Dye JM, Consortium GET. Convalescent plasma for Ebola virus disease. N Engl J Med. 2016;374(25):2498-2500.
Caballero IS, Honko AN, Gire SK, Winnicki SM, Mele M, Gerhardinger C, Lin AE, Rinn JL, Sabeti PC, Hensley LE, Connor JH. In vivo Ebola virus infection leads to a strong innate response in circulating immune cells. Bmc Genomics. 2016;17:13. doi: 10.1186/s12864-016-3060-0.
Cardile AP, Downey LG, Wiseman PD, Warren TK, Bavari S. Antiviral therapeutics for the treatment of Ebola virus infection. Curr Opin Pharmacol. 2016;30:138-43. doi: 10.1016/j.coph.2016.08.016.
Cazares LH, Ward MD, Brueggemann EE, Kenny T, Demond P, Mahone CR, Martins KAO, Nuss JE, Glaros T, Bavari S. Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparations. Clin Proteomics. 2016;13:18. doi: 10.1186/s12014-016-9119-8.
Chabot DJ, Ribot WJ, Joyce J, Cook J, Hepler R, Nahas D, Chua J, Friedlander AM. Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine. Vaccine. 2016;34(34):4012-6. doi: 10.1016/j.vaccine.2016.06.031.
Chahal JS, Khan OF, Cooper CL, McPartlan JS, Tsosie JK, Tilley LD, Sidik SM, Lourido S, Langer R, Bavari S, Ploegh HL, Anderson DG. Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose. Proc Natl Acad Sci U S A. 2016;113(29):E4133-E42. doi: 10.1073/pnas.1600299113.
Chaudhury S, Ockenhouse CF, Regules JA, Dutta S, Wallqvist A, Jongert E, Waters NC, Lemiale F, Bergmann-Leitner E. The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity. Malar J. 2016;15:12. doi: 10.1186/s12936-016-1348-9.
Cnops L, van Griensven J, Honko AN, Bausch DG, Sprecher A, Hill CE, Colebunders R, Johnson JC, Griffiths A, Palacios GF, Kraft CS, Kobinger G, Hewlett A, Norwood DA, Sabeti P, Jahrling PB, Formenty P, Kuhn JH, Arien KK. Essentials of filoviral load quantification. Lancet Infect Dis. 2016;16(7):E134-E8. doi: 10.1016/s1473-3099(16)30063-9.
Cnops L, van Griensven J, Honko AN, Bausch DG, Sprecher A, Hill CE, Colebunders R, Johnson JC, Griffiths A, Palacios GF, Kraft CS, Kobinger G, Hewlett A, Norwood DA, Sabeti P, Jahrling PB, Formenty P, Kuhn JH, Arien KK. Overlooking the importance of immunoassays reply. Lancet Infect Dis. 2016;16(10):1110. doi: 10.1016/S1473-3099(16)30339-5.
Cohen CA, Bakken R, Glass PJ. A trivalent alphavirus virus-like replicon particle vaccine induces cell-mediated responses against conserved glycoprotein regions. J Immunol. 2016;196:1.
Cong Y, Dyall J, Hart BJ, DeWald LE, Johnson JC, Postnikova E, Zhou H, Gross R, Rojas O, Alexander I, Josleyn N, Zhang T, Michelotti J, Janosko K, Glass PJ, Flint M, McMullan LK, Spiropoulou CF, Mierzwa T, Guha R, Shinn P, Michael S, Klumpp-Thomas C, McKnight C, Thomas C, Eakin AE, O'Loughlin KG, Green CE, Catz P, Mirsalis JC, Honko AN, Olinger GG, Bennett RS, Holbrook MR, Hensley LE, Jahrling PB. Evaluation of the activity of Lamivudine and Zidovudine against Ebola Virus. PLoS One. 2016;11(11):19. doi: 10.1371/journal.pone.0166318.
Corti D, Misasi J, Mulangu S, Stanley DA, Kanekiyo M, Wollen S, Ploquin A, Doria-Rose NA, Staupe RP, Bailey M, Shi W, Choe M, Marcus H, Thompson EA, Cagigi A, Silacci C, Fernandez-Rodriguez B, Perez L, Sallusto F, Vanzetta F, Agatic G, Cameroni E, Kisalu N, Gordon I, Ledgerwood JE, Mascola JR, Graham BS, Muyembe-Tamfun JJ, Trefry JC, Lanzavecchia A, Sullivan NJ. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science. 2016;351(6279):1339-42. doi: 10.1126/science.aad5224.
Duplantier AJ, Kane CD, Bavari S. Searching for therapeutics against Botulinum neurotoxins: A true challenge for drug discovery. Curr Top Med Chem. 2016;16(21):2330-49. doi: 10.2174/1568026616666160413135630.
Duy J, Koehler JW, Honko AN, Schoepp RJ, Wauquier N, Gonzalez JP, Pitt ML, Mucker EM, Johnson JC, O'Hearn A, Bangura J, Coomber M, Minogue TD. Circulating microRNA profiles of Ebola virus infection. Sci Rep. 2016;6:13. doi: 10.1038/srep24496.
Dye JM, Warfield KL, Wells JB, Unfer RC, Shulenin S, Vu H, Nichols DK, Aman MJ, Bavari S. Virus-like particle vaccination protects nonhuman primates from lethal aerosol exposure with Marburgvirus (VLP vaccination protects Macaques against aerosol challenges). Viruses. 2016;8(4):15. doi: 10.3390/v8040094.
Dye JM, Wu H, Hooper JW, Khurana S, Kuehne AI, Coyle EM, Ortiz RA, Fuentes S, Herbert AS, Golding H, Bakken RA, Brannan JM, Kwilas SA, Sullivan EJ, Luke TC, Smith G, Glenn G, Li WF, Ye L, Yang CL, Compans RW, Tripp RA, Jiao JA. Production of potent fully human polyclonal antibodies against Ebola Zaire virus in transchromosomal cattle. Sci Rep. 2016;6:9. doi: 10.1038/srep24897.
Erukula SV, Srivari Y, Chatterjee P. Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns). J Microencapsul. 2016;33(6):524-34. doi: 10.1080/02652048.2016.1222006.
Evans JC, Trujillo C, Wang Z, Eoh H, Ehrt S, Schnappinger D, Boshoff HIM, Rhee KY, Barry CE, Mizrahi V. Validation of CoaBC as a bactericidal target in the coenzyme a pathway of Mycobacterium tuberculosis. ACS Infect Dis. 2016;2(12):70-80. doi: 10.1021/acsinfecdis.6b00150.
Ewers EC, Pratt WD, Twenhafel NA, Shamblin J, Donnelly G, Esham H, Wlazlowski C, Johnson JC, Botto M, Hensley LE, Goff AJ. Natural history of aerosol exposure with Marburg virus in Rhesus Macaques. Viruses. 2016;8(4):16. doi: 10.3390/v8040087.
Farooq F, Beck K, Paolino KM, Phillips R, Waters NC, Regules JA, Bergmann-Leitner ES. Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine. Sci Rep. 2016;6:9. doi: 10.1038/srep27944.
Folarin OA, Ehichioya D, Schaffner SF, Winnicki SM, Wohl S, Eromon P, West KL, Gladden-Young A, Oyejide NE, Matranga CB, Deme AB, James A, Tomkins-Tinch C, Onyewurunwa K, Ladner JT, Palacios G, Nosamiefan I, Andersen KG, Omilabu S, Park DJ, Yozwiak NL, Nasidi A, Garry RF, Tomori O, Sabeti PC, Happi CT. Ebola virus epidemiology and evolution in Nigeria. J Infect Dis. 2016;214:S102-S9. doi: 10.1093/infdis/jiw190.
Fraga M, Vilarino N, Louzao MC, Fernandez DA, Poli M, Botana LM. Detection of palytoxin-like compounds by a flow cytometry-based immunoassay supported by functional and analytical methods. Anal Chim Acta. 2016;903:1-12. doi: 10.1016/j.aca.2015.09.040.
Frei JC, Nyakatura EK, Zak SE, Bakken RR, Chandran K, Dye JM, Lai JR. Bispecific antibody affords complete post-exposure protection of mice from both Ebola (Zaire) and Sudan viruses. Sci Rep. 2016;6:10. doi: 10.1038/srep19193.
Golden JW, Maes P, Kwilas SA, Ballantyne J, Hooper JW. Glycoprotein-specific antibodies produced by DNA vaccination protect guinea pigs from lethal Argentine and Venezuelan hemorrhagic fever. J Virol. 2016;90(7):3515-29. doi: 10.1128/jvi.02969-15.
Gupta P, Sharma A, Spurgers KB, Bakken RR, Eccleston LT, Cohen JW, Honnold SP, Glass PJ, Maheshwari RK. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus. Vaccine. 2016;34(25):2762-5. doi: 10.1016/j.vaccine.2016.04.049.
Haddow AD, Nasar F, Guzman H, Ponlawat A, Jarman RG, Tesh RB, Weaver SC. Genetic characterization of Spondweni and Zika viruses and susceptibility of geographically distinct strains of Aedes aegypti, Aedes albopictus and Culex quinquefasciatus (Diptera: Culicidae) to Spondweni virus. PLoS Negl Trop Dis. 2016;10(10):13. doi: 10.1371/journal.pntd.0005083.
Haddow AD, Woodall JP. Distinguishing between Zika and Spondweni viruses. Bull World Health Organ. 2016;94(10):711-. doi: 10.2471/blt.16.181503.
Hammerbeck CD, Brocato RL, Bell TM, Schellhase CW, Mraz SR, Queen LA, Hooper JW. Depletion of alveolar macrophages does not prevent Hantavirus disease pathogenesis in golden Syrian hamsters. J Virol. 2016;90(14):6200-15. doi: 10.1128/jvi.00304-16.
Hannaman D, Dupuy LC, Ellefsen B, Schmaljohn CS. A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation. Vaccine. 2016;34(31):3607-12. doi: 10.1016/j.vaccine.2016.04.077.
Holley AB, Sobieszczyk M, Perkins M, Cohee BM, Costantoth CB, Mabe DL, Liotta R, Abraham JH, Holley PR, Sherner J. Lung function abnormalities among service members returning from Iraq or Afghanistan with respiratory complaints. Respir Med. 2016;118:84-7. doi: 10.1016/j.rmed.2016.07.014.
Holtsberg FW, Shulenin S, Vu H, Howell KA, Patel SJ, Gunn B, Karim M, Lai JR, Frei JC, Nyakatura EK, Zeitlin L, Douglas R, Fusco ML, Froude JW, Saphire EO, Herbert AS, Wirchnianski AS, Lear-Rooney CM, Alter G, Dye JM, Glass PJ, Warfield KL, Aman MJ. Pan-ebolavirus and Pan-filovirus mouse monoclonal antibodies: Protection against Ebola and Sudan viruses. J Virol. 2016;90(1):266-78. doi: 10.1128/jvi.02171-15.
Hostler DC, Marx ES, Moores LK, Petteys SK, Hostler JM, Mitchell JD, Holley PR, Collen JF, Foster BE, Holley AB. Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score. Chest. 2016;149(2):372-9. doi: 10.1378/chest.14-2842.
Howell KA, Qiu XG, Brannan JM, Bryan C, Davidson E, Holtsberg FW, Wec AZ, Shulenin S, Biggins JE, Douglas R, Enterlein SG, Turner HL, Pallesen J, Murin CD, He SH, Kroeker A, Vu H, Herbert AS, Fusco ML, Nyakatura EK, Lai JR, Keck ZY, Foung SKH, Saphire EO, Zeitlin L, Ward AB, Chandran K, Doranz BJ, Kobinger GP, Dye JM, Aman MJ. Antibody treatment of Ebola and Sudan virus infection via a uniquely exposed epitope within the glycoprotein receptor-binding site. Cell Rep. 2016;15(7):1514-26. doi: 10.1016/j.celrep.2016.04.026.
Hu X, Compton JR, Leary DH, Olson MA, Lee MS, Cheung J, Ye W, Ferrer M, Southall N, Jadhav A, Morazzani EM, Glass PJ, Marugan J, Legler PM. Kinetic, mutational, and structural studies of the Venezuelan Equine Encephalitis virus nonstructural protein 2 cysteine protease. Biochemistry. 2016;55(21):3007-19. doi: 10.1021/acs.biochem.5b00992.
Keasey SL, Natesan M, Pugh C, Kamata T, Wuchty S, Ulrich RG. Cell-free Determination of binary complexes that comprise extended protein-protein interaction networks of Yersinia pestis. Mol Cell Proteomics. 2016;15(10):3220-32. doi: 10.1074/mcp.M116.059337.
Keck ZY, Enterlein SG, Howell KA, Vu H, Shulenin S, Warfield KL, Froude JW, Araghi N, Douglas R, Biggins J, Lear-Rooney CM, Wirchnianski AS, Lau P, Wang Y, Herbert AS, Dye JM, Glass PJ, Holtsberg FW, Foung SKH, Aman MJ. Macaque monoclonal antibodies targeting novel conserved epitopes within filovirus glycoprotein. J Virol. 2016;90(1):279-91. doi: 10.1128/jvi.02172-15.
Kim WK, Kim JA, Song DH, Lee D, Kim YC, Lee SY, Lee SH, No JS, Kim JH, Kho JH, Gu SH, Jeong ST, Wiley M, Kim HC, Klein TA, Palacios G, Song JW. Phylogeographic analysis of hemorrhagic fever with renal syndrome patients using multiplex PCR-based next generation sequencing. Sci Rep. 2016;6:8. doi: 10.1038/srep26017.
Konduru K, Shurtleff AC, Bradfute SB, Nakamura S, Bavari S, Kaplan G. Ebolavirus glycoprotein Fc fusion protein protects guinea pigs against lethal challenge. PLoS One. 2016;11(9):21. doi: 10.1371/journal.pone.0162446.
Konongoi L, Ofula V, Nyunja A, Owaka S, Koka H, Makio A, Koskei E, Eyase F, Langat D, Schoepp RJ, Rossi CA, Njeru I, Coldren R, Sang R. Detection of dengue virus serotypes 1, 2 and 3 in selected regions of Kenya: 2011-2014. Virol J. 2016;13:11. doi: 10.1186/s12985-016-0641-0.
Koontz JM, Kumsher DM, Kelly R, Stallings JD. Effect of 2 bedding materials on ammonia levels in individually ventilated cages. J Am Assoc Lab Anim Sci. 2016;55(1):25-8.
Kortepeter MG, Kwon EH, Hewlett AL, Smith PW, Cieslak TJ. Containment care units for managing patients with highly hazardous infectious diseases: A concept whose time has come. J Infect Dis. 2016;214:S137-S41. doi: 10.1093/infdis/jiw292.
Krakauer T. Enterotoxins: Microbial proteins and host cell dysregulation. Toxins. 2016;8(1):4. doi: 10.3390/toxins8010017.
Krakauer T, Pradhan K, Stiles BG. Staphylococcal superantigens spark host-mediated danger signals. Front Immunol. 2016;7:14. doi: 10.3389/fimmu.2016.00023.
Krishnamurthy M, Moore RT, Rajamani S, Panchal RG. Bacterial genome engineering and synthetic biology: combating pathogens. BMC Microbiol. 2016;16:11. doi: 10.1186/s12866-016-0876-3.
Kuchuloria T, Imnadze P, Mamuchishvili N, Chokheli M, Tsertsvadze T, Endeladze M, Mshvidobadze K, Gatserelia L, Makhviladze M, Kanashvili M, Mikautadze T, Nanuashvili A, Kiknavelidze K, Kokaia N, Makharadze M, Clark DV, Bautista CT, Farrell M, Fadeel MA, Maksoud MA, Pimentel G, House B, Hepburn MJ, Rivard RG. Hospital-based surveillance for infectious etiologies among patients with acute febrile illness in Georgia, 2008-2011. Am J Trop Med Hyg. 2016;94(1):236-42. doi: 10.4269/ajtmh.15-0400.
Kugelman JR, Rossi CA, Wiley MR, Ladner JT, Nagle ER, Pfeffer BP, Garcia K, Prieto K, Wada J, Kuhn JH, Palacios G. Informing the historical record of experimental nonhuman primate infections with Ebola virus: Genomic characterization of USAMRIID Ebola virus/H.sapiens-tc/COD/1995/Kikwit-9510621 challenge stock "R4368" and its replacement "R4415". PLoS One. 2016;11(3):9. doi: 10.1371/journal.pone.0150919.
Kuhn JH, Lauck M, Bailey AL, Shchetinin AM, Vishnevskaya TV, Bao YM, Ng TFF, LeBreton M, Schneider BS, Gillis A, Tamoufe U, Diffo JL, Takuo JM, Kondov NO, Coffey LL, Wolfe ND, Delwart E, Clawson AN, Postnikova E, Bollinger L, Lackemeyer MG, Radoshitzky SR, Palacios G, Wada J, Shevtsova ZV, Jahrling PB, Lapin BA, Deriabin PG, Dunowska M, Alkhovsky SV, Rogers J, Friedrich TC, O'Connor DH, Goldberg TL. Reorganization and expansion of the nidoviral family Arteriviridae. Arch Virol. 2016;161(3):755-68. doi: 10.1007/s00705-015-2672-z.
Kuhn JH, Wiley MR, Rodriguez SE, Bao YM, Prieto K, da Rosa A, Guzman H, Savji N, Ladner JT, Tesh RB, Wada J, Jahrling PB, Bente DA, Palacios G. Genomic characterization of the Genus Nairovirus (Family Bunyaviridae). Viruses. 2016;8(6):27. doi: 10.3390/v8060164.
Ladner JT, Kuhn JH, Palacios G. Standard finishing categories for high-throughput sequencing of viral genomes. Rev Sci Tech. 2016;35(1):43-52. doi: 10.20506/rst.35.1.2416.
Ladner JT, Wiley MR, Beitzel B, Auguste AJ, Dupuis AP, Lindquist ME, Sibley SD, Kota KP, Fetterer D, Eastwood G, Kimmel D, Prieto K, Guzman H, Aliota MT, Reyes D, Brueggemann EE, John LS, Hyeroba D, Lauck M, Friedrich TC, O'Connor DH, Gestole MC, Cazares LH, Popov VL, Castro-Llanos F, Kochel TJ, Kenny T, White B, Ward MD, Loaiza JR, Goldberg TL, Weaver SC, Kramer LD, Tesh RB, Palacios G. A multicomponent animal virus isolated from mosquitoes. Cell Host Microbe. 2016;20(3):357-67. doi: 10.1016/j.chom.2016.07.011.
Laws TR, Kuchuloria T, Chitadze N, Little SF, Webster WM, Debes AK, Saginadze S, Tsertsvadze N, Chubinidze M, Rivard RG, Tsanava S, Dyson EH, Simpson AJH, Hepburn MJ, Trapaidze N. A comparison of the adaptive immune response between recovered anthrax patients and individuals receiving three different anthrax vaccines. PLoS One. 2016;11(3):16. doi: 10.1371/journal.pone.0148713.
Lee BY, Bartsch SM, Wong KF, McKinnell JA, Slayton RB, Miller LG, Cao CH, Kim DS, Kallen AJ, Jernigan JA, Huang SS. The potential trajectory of carbapenem-resistant enterobacteriaceae, an emerging threat to health-care facilities, and the impact of the Centers for Disease Control and prevention toolkit. M J Epidemiol. 2016;183(5):471-9. doi: 10.1093/aje/kwv299.
Leonardi W, Zilbermintz L, Cheng LW, Zozaya J, Tran SH, Elliott JH, Polukhina K, Manasherob R, Li A, Chi XL, Gharaibeh D, Kenny T, Zamani R, Soloveva V, Haddow AD, Nasar F, Bavari S, Bassik MC, Cohen SN, Levitin A, Martchenko M. Bithionol blocks pathogenicity of bacterial toxins, ricin, and Zika virus. Sci Rep. 2016;6:12. doi: 10.1038/srep34475.
Markwalter CF, Ricks KM, Bitting AL, Mudenda L, Wright DW. Simultaneous capture and sequential detection of two malarial biomarkers on magnetic microparticles. Talanta. 2016;161:443-9. doi: 10.1016/j.talanta.2016.08.078.
Martins KA, Jahrling PB, Bavari S, Kuhn JH. Ebola virus disease candidate vaccines under evaluation in clinical trials. Expert Rev Vaccines. 2016;15(9):1101-12. doi: 10.1080/14760584.2016.1187566.
Martins KAO, Dye JM, Bavari S. Considerations for the development of Zika virus vaccines. Vaccine. 2016;34(33):3711-2. doi: 10.1016/j.vaccine.2016.06.012.
Memisevic V, Kumar K, Zavaljevski N, DeShazer D, Wallqvist A, Reifman J. DBSecSys 2.0: a database of Burkholderia mallei and Burkholderia pseudomallei secretion systems. Bmc Bioinformatics. 2016;17:7. doi: 10.1186/s12859-016-1242-z.
Millar EV, Schlett CD, Law NN, Chen WJ, D'Onofrio MJ, Bennett JW, Tribble DR, Ellis MW. Reduction in acute respiratory infection among military trainees: Secondary effects of a hygiene-based cluster-randomized trial for skin and soft-tissue infection prevention. Infect Control Hosp Epidemiol. 2016;37(9):1118-20. doi: 10.1017/ice.2016.154.
Molohon KJ, Blair PM, Park S, Doroghazi JR, Maxson T, Hershfield JR, Flatt KM, Schroeder NE, Ha T, Mitchell DA. Plantazolicin is an ultranarrow-spectrum antibiotic that targets the Bacillus anthracis membrane. ACS Infect Dis. 2016;2(3):207-20. doi: 10.1021/acsinfecdis.5b00115.
Monninger MK, Nguessan CA, Blancett CD, Kuehl KA, Rossi CA, Olschner SP, Williams PL, Goodman SL, Sun MG. Preparation of viral samples within biocontainment for ultrastructural analysis: Utilization of an innovative processing capsule for negative staining. J Virol Methods. 2016;238:70-6. doi: 10.1016/j.jviromet.2016.10.005.
Mudhasani R, Tran JP, Retterer C, Kota KP, Whitehouse CA, Bavari S. Protein Kinase R Degradation is essential for Rift Valley Fever virus infection and is regulated by SKP1-CUL1-F-box (SCF)(FBXW11-NSs) E3 Ligase. PLoS Pathog. 2016;12(2):27. doi: 10.1371/journal.ppat.1005437.
Natesan M, Jensen SM, Keasey SL, Kamata T, Kuehne AI, Stonier SW, Lutwama JJ, Lobel L, Dye JM, Ulrich RG. Human survivors of disease outbreaks caused by Ebola or Marburg virus exhibit cross-reactive and long-lived antibody responses. Clin Vaccine Immunol. 2016;23(8):717-24. doi: 10.1128/cvi.00107-16.
O'Hearn AE, Voorhees MA, Fetterer DP, Wauquier N, Coomber MR, Bangura J, Fair JN, Gonzalez JP, Schoepp RJ. Serosurveillance of viral pathogens circulating in West Africa. Virol J. 2016;13:6. doi: 10.1186/s12985-016-0621-4.
Olsen ME, Filone CM, Rozelle D, Mire CE, Agans KN, Hensley L, Connor JH. Polyamines and hypusination are required for Ebolavirus gene expression and replication. MBio. 2016;7(4):10. doi: 10.1128/MBio.00882-16.
Olson MA, Legler PM, Goldman ER. Comparison of replica exchange simulations of a kinetically trapped protein conformational state and its native form. J Phys Chem B. 2016;120(9):2234-40. doi: 10.1021/acs.jpcb.6b00233.
Papa A, Vaheri A, LeDuc JW, Kruger DH, Avsic-Zupanc T, Arikawa J, Song JW, Markotic A, Clement J, Liang MF, Li DX, Yashina LN, Jonsson CB, Schmaljohn CS. Meeting report: Tenth International Conference on Hantaviruses. Antiviral Res. 2016;133:234-41. doi: 10.1016/j.antiviral.2016.08.015.
Paronyan L, Zardaryan E, Bakunts V, Gevorgyan Z, Asoyan V, Apresyan H, Hovhannisyan A, Palayan K, Bautista CT, Kuchuloria T, Rivard RG. A retrospective chart review study to describe selected zoonotic and arboviral etiologies in hospitalized febrile patients in the Republic of Armenia. BMC Infect Dis. 2016;16:8. doi: 10.1186/s12879-016-1764-z
Pelin M, Forino M, Brovedani V, Tartaglione L, Dell'Aversano C, Pistocchi R, Poli M, Sosa S, Florio C, Ciminiello P, Tubaro A. Ovatoxin-a, a palytoxin analogue isolated from Ostreopsis cf. ovata Fukuyo: Cytotoxic activity and ELISA detection. Environ Sci Technol. 2016;50(3):1544-51. doi: 10.1021/acs.est.5b04749.
Phan JC, Pettitt J, George JS, Fakoli LS, Taweh FM, Bateman SL, Bennett RS, Norris SL, Spinnler DA, Pimentel G, Sahr PK, Bolay FK, Schoepp RJ. Lateral flow immunoassays for Ebola virus disease detection in Liberia. J Infect Dis. 2016;214:S222-S8. doi: 10.1093/infdis/jiw251.
Pittman PR, McClain D, Quinn X, Coonan KM, Mangiafico J, Makuch RS, Morrill J, Peters CJ. Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans. Vaccine. 2016;34(4):424-9. doi: 10.1016/j.vaccine.2015.12.030.
Pittman PR, Norris SL, Brown ES, Ranadive MV, Schibly BA, Bettinger GE, Lokugamage N, Korman L, Morrill JC, Peters CJ. Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates. Vaccine. 2016;34(4):523-30. doi: 10.1016/j.vaccine.2015.11.078.
Prugar LI, Dye JM, Loughran M, Wrobel JE, Reitz AB, Freedman BD, Harty RN, Herbert AS. Small-molecule probe targeting viral PPxY L-domain inhibits filovirus and arenavirus egress. J Immunol. 2016;196:1.
Pugh C, Brown ES, Quinn XF, Korman L, Dyas BK, Ulrich RG, Pittman PR. Povidone iodine ointment application to the vaccination site does not alter immunoglobulin G antibody response to smallpox vaccine. Viral Immunol. 2016;29(6):361-6. doi: 10.1089/vim.2016.0025.
Radoshitzky SR, Pegoraro G, Chi XL, Dong L, Chiang CY, Jozwick L, Clester JC, Cooper CL, Courier D, Langan DP, Underwood K, Kuehl KA, Sun MG, Cai YY, Yu SQ, Burk R, Zamani R, Kota K, Kuhn JH, Bavari S. siRNA screen identifies trafficking host factors that modulate alphavirus infection. PLoS Pathog. 2016;12(3):30. doi: 10.1371/journal.ppat.1005466.
Regules JA, Cicatelli SB, Bennett JW, Paolino KM, Twomey PS, Moon JE, Kathcart AK, Hauns KD, Komisar JL, Qabar AN, Davidson SA, Dutta S, Griffith ME, Magee CD, Wojnarski M, Livezey JR, Kress AT, Waterman PE, Jongert E, Wille-Reece U, Volkmuth W, Emerling D, Robinson WH, Lievens M, Morelle D, Lee CK, Yassin-Rajkumar B, Weltzin R, Cohen J, Paris RM, Waters NC, Birkett AJ, Kaslow DC, Ballou WR, Ockenhouse CF, Vekemans J. Fractional third and fourth dose of RTS,S/AS01 malaria candidate vaccine: A Phase 2a controlled human malaria parasite infection and immunogenicity study. J Infect Dis. 2016;214(5):762-71. doi: 10.1093/infdis/jiw237.
Riblett AM, Blomen VA, Jae LT, Altamura LA, Doms RW, Brummelkamp TR, Wojcechowskyj JA. A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection. J Virol. 2016;90(3):1414-23. doi: 10.1128/jvi.02055-15.
Ruiz SI, El-Gendy N, Bowen LE, Berkland C, Bailey MM. Formulation and characterization of nanocluster Ceftazidime for the treatment of acute pulmonary melioidosis. J Pharm Sci. 2016;105(11):3399-408. doi: 10.1016/j.xphs.2016.07.029.
Samuel GH, Wiley MR, Badawi A, Adelman ZN, Myles KM. Yellow fever virus capsid protein is a potent suppressor of RNA silencing that binds double-stranded RNA. Proc Natl Acad Sci U S A. 2016;113(48):13863-8. doi: 10.1073/pnas.1600544113.
Shurtleff AC, Bloomfield HA, Mort S, Orr SA, Audet B, Whitaker T, Richards MJ, Bavari S. Validation of the filovirus plaque assay for use in preclinical studies. Viruses. 2016;8(4):20. doi: 10.3390/v8040113.
Sobarzo A, Stonier SW, Herbert AS, Ochayon DE, Kuehne AI, Eskira Y, Fedida-Metula S, Tali N, Lewis EC, Egesa M, Cose S, Lutwama JJ, Yavelsky V, Dye JM, Lobel L. Correspondence of neutralizing humoral immunity and CD4 T cell responses in long recovered Sudan virus survivors. Viruses. 2016;8(5):12. doi: 10.3390/v8050133.
Spengler JR, Estrada-Pena A, Garrison AR, Schmaljohn C, Spiropoulou CF, Bergeron E, Bente DA. A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus. Antiviral Res. 2016;135:31-47. doi: 10.1016/j.antivira1.2016.09.013.
Stefan CP, Chase K, Coyne S, Kulesh DA, Minogue TD, Koehler JW. Development of real-time reverse transcriptase qPCR assays for the detection of Punta Toro virus and Pichinde virus. Virol J. 2016;13:6. doi: 10.1186/s12985-016-0509-3.
Stefan CP, Koehler JW, Minogue TD. Targeted next-generation sequencing for the detection of ciprofloxacin resistance markers using molecular inversion probes. Sci Rep. 2016;6:12. doi: 10.1038/srep25904.
Stonier SW, James RM, Josleyn NM, Bakken RR, Dye JM. Immune correlates for VEEV replicon vaccine protection against Ebolavirus. J Immunol. 2016;196:2.
Sugiharto VA, Grieco JP, Murphy JR, Olsen CH, Colacicco-Mayhugh MG, Stewart VA, Achee NL, Turell MJ. Effects of preexposure to DEET on the downstream blood-feeding behaviors of Aedes aegypti (Diptera: Culicidae) mosquitoes. J Med Entomol. 2016;53(5):1100-4. doi: 10.1093/jme/tjw066.
Sugiharto VA, Murphy JR, Turell MJ, Olsen CH, Stewart VA, Colacicco-Mayhugh MG, Grieco JP, Achee NL. Dengue virus-1 infection did not alter the behavioral response of Aedes aegypti (Diptera: Culicidae) to DEET. J Med Entomol. 2016;53(3):687-91. doi: 10.1093/jme/tjw030.
Tran EEH, Nelson EA, Bonagiri P, Simmons JA, Shoemaker CJ, Schmaljohn CS, Kobinger GP, Zeitlin L, Subramaniam S, White JM. Mapping of Ebolavirus neutralization by monoclonal antibodies in the ZMapp cocktail using cryo-electron tomography and studies of cellular entry. J Virol. 2016;90(17):7618-27. doi: 10.1128/jvi.00406-16.
Treangen TJ, Schoeler G, Phillippy AM, Bergman NH, Turell MJ. Identification and genomic analysis of a novel group C orthobunyavirus isolated from a mosquito captured near Iquitos, Peru. PLoS Negl Trop Dis. 2016;10(4):13. doi: 10.1371/journal.pntd.0004440.
van der Linden WA, Schulze CJ, Herbert AS, Krause TB, Wirchnianski AA, Dye JM, Chandran K, Bogyo M. Cysteine cathepsin inhibitors as anti-Ebola agents. ACS Infect Dis. 2016;2(3):173-9. doi: 10.1021/acsinfecdis.5b00130.
van Vuren PJ, Wiley M, Palacios G, Storm N, McCulloch S, Markotter W, Birkhead M, Kemp A, Paweska JT. Isolation of a novel fusogenic orthoreovirus from eucampsipoda africana bat flies in South Africa. Viruses. 2016;8(3):25. doi: 10.3390/v8030065.
Wahl-Jensen V, Johnson JC, Lauck M, Weinfurter JT, Moncla LH, Weiler AM, Charlier O, Rojas O, Byrum R, Ragland DR, Huzella L, Zommer E, Cohen M, Bernbaum JG, Cai YY, Sanford HB, Mazur S, Johnson RF, Qin J, Palacios GF, Bailey AL, Jahrling PB, Goldberg TL, O'Connor DH, Friedrich TC, Kuhn JH. Divergent simian arteriviruses cause simian hemorrhagic fever of differing severities in macaques. MBio. 2016;7(1):10. doi: 10.1128/MBio.02009-15.
Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC, Larson N, Strickley R, Wells J, Stuthman KS, Van Tongeren SA, Garza NL, Donnelly G, Shurtleff AC, Retterer CJ, Gharaibeh D, Zamani R, Kenny T, Eaton BP, Grimes E, Welch LS, Gomba L, Wilhelmsen CL, Nichols DK, Nuss JE, Nagle ER, Kugelman JR, Palacios G, Doerffler E, Neville S, Carra E, Clarke MO, Zhang LJ, Lew W, Ross B, Wang Q, Chun K, Wolfe L, Babusis D, Park Y, Stray KM, Trancheva I, Feng JY, Barauskas O, Xu YL, Wong P, Braun MR, Flint M, McMullan LK, Chen SS, Fearns R, Swaminathan S, Mayers DL, Spiropoulou CF, Lee WA, Nichol ST, Cihlar T, Bavari S. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016;531(7594):381-+. doi: 10.1038/nature17180.
Warren TK, Whitehouse CA, Wells J, Welch L, Charleston JS, Heald A, Nichols DK, Mattix ME, Palacios G, Kugleman JR, Iversen PL, Bavari S. Delayed time-to-treatment of an antisense morpholino oligomer is effective against lethal Marburg virus infection in Cynomolgus macaques. PLoS Negl Trop Dis. 2016;10(2):18. doi: 10.1371/journal.pntd.0004456.
Watson DC, Bayik D, Srivatsan A, Bergamaschi C, Valentin A, Niu G, Bear J, Monninger M, Sun M, Morales-Kastresana A, Jones JC, Felber BK, Chen XY, Gursel I, Pavlakis GN. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials. 2016;105:195-205. doi: 10.1016/j.biomaterials.2016.07.003.
Wec AZ, Nyakatura EK, Herbert AS, Howell KA, Holtsberg FW, Bakken RR, Mittler E, Christin JR, Shulenin S, Jangra RK, Bharrhan S, Kuehne AI, Bornholdt ZA, Flyak AI, Saphire EO, Crowe JE, Aman MJ, Dye JM, Lai JR, Chandran K. A "Trojan horse" bispecific-antibody strategy for broad protection against ebolaviruses. Science. 2016;354(6310):350-4. doi: 10.1126/science.aag3267.
Weidmann M, Avsic-Zupanc T, Bino S, Bouloy M, Burt F, Chinikar S, Christova I, Dedushaj I, El-Sanousi A, Elaldi N, Hewson R, Hufert FT, Humolli I, van Vuren PJ, Tufan ZK, Korukluoglu G, Lyssen P, Mirazimi A, Neyts J, Niedrig M, Ozkul A, Papa A, Paweska J, Sall AA, Schmaljohn CS, Swanepoel R, Uyar Y, Weber F, Zeller H. Biosafety standards for working with Crimean-Congo hemorrhagic fever virus. J Gen Virol. 2016;97:2799-808. doi: 10.1099/jgv.0.000610.
Williamson CHD, Sahl JW, Smith TJ, Xie G, Foley BT, Smith LA, Fernandez RA, Lindstrom M, Korkeala H, Keim P, Foster J, Hill K. Comparative genomic analyses reveal broad diversity in botulinum-toxin-producing Clostridia. Bmc Genomics. 2016;17:20. doi: 10.1186/s12864-016-2502-z.
Wong KK, Davey RT, Hewlett AL, Kraft CS, Mehta AK, Mulligan MJ, Beck A, Dorman W, Kratochvil CJ, Lai LL, Palmore TN, Rogers S, Smith P, Suffredini AF, Wolcott M, Stroher U, Uyeki TM. Use of postexposure prophylaxis after occupational exposure to Zaire Ebolavirus. Clin Infect Dis. 2016;63(3):376-9. doi: 10.1093/cid/ciw256.
Yu GY, Mate S, Garcia K, Ward MD, Brueggemann E, Hall M, Kenny T, Sanchez-Lockhart M, Lefranc MP, Palacios G. Cynomolgus macaque (Macaca fascicularis) immunoglobulin heavy chain locus description. Immunogenetics. 2016;68(6-7):417-28. doi: 10.1007/s00251-016-0921-2.
Yu SQ, Cai YY, Lyons C, Johnson RF, Postnikova E, Mazur S, Johnson JC, Radoshitzky SR, Bailey AL, Lauck M, Goldberg TL, O'Connor DH, Jahrling PB, Friedrich TC, Kuhn JH. Specific detection of two divergent simian arteriviruses using RNAscope in situ hybridization. PLoS One. 2016;11(3):9. doi: 10.1371/journal.pone.0151313.
Zardaryan E, Paronyan L, Bakunts V, Gevorgyan Z, Asoyan V, Apresyan H, Hovhannisyan A, Palayan K, Kuchuloria T, Rivard RG, Bautista CT. Intestinal infections among febrile hospitalized patients in the Republic of Armenia: A retrospective chart review. J Community Health. 2016;41(5):939-45. doi: 10.1007/s10900-016-0174-x.
Zeitlin L, Geisbert JB, Deer DJ, Fenton KA, Bohorov O, Bohorova N, Goodman C, Kim D, Hiatt A, Pauly MH, Velasco J, Whaley KJ, Altmann F, Gruber C, Steinkellner H, Honko AN, Kuehne AI, Aman MJ, Sahandi S, Enterlein S, Zhan XG, Enria D, Geisbert TW. Monoclonal antibody therapy for Junin virus infection. Proc Natl Acad Sci U S A. 2016;113(16):4458-63. doi: 10.1073/pnas.1600996113.
|
SITEMAP
ARMY.MIL 
